Search for: "UNITED STATES PATENT AND TRADEMARK OFFICE" Results 2181 - 2200 of 6,104
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
14 Nov 2017, 8:10 am
Long Delayed Fee Increase Hits January 16th Section 10 of the Leahy‐Smith America Invents Act (AIA) authorizes the United States Patent and Trademark Office (USPTO) to, in part, “set or adjust by rule any fee established, authorized, or charged” under Title 35 of the United States Code. [read post]
14 Nov 2017, 6:53 am by James Yang
Supplemental register versus principal register The United States Patent and Trademark Office (USPTO) maintains two different lists that identify registered trademarks in the United States. [read post]
14 Nov 2017, 6:53 am by James Yang
  Supplemental register versus principal register The United States Patent and Trademark Office (USPTO) maintains two different lists that identify registered trademarks in the United States. [read post]
13 Nov 2017, 4:00 am by Ed. Microjuris.com Puerto Rico
Tener una patente, en jurisdicción estadounidense, por un producto útil o diseño o una planta requiere que ésta sea otorgada por el United States Patent and Trademark Office (el “USPTO”). [read post]
12 Nov 2017, 7:25 am by Legal Profession Prof
The respondent also practiced before the United States Patent and Trademark Office (USPTO) in trademark matters and was subject to the... [read post]
8 Nov 2017, 10:16 am by Jo Dale Carothers
The Leahy-Smith America Invents Act (“AIA”) provided for trials before the Patent Trial and Appeal Board (“PTAB”) of the United States Patent and Trademark Office (“USPTO”) in inter partes reviews, post-grant reviews, the transitional program for covered business method patents, and derivation proceedings. [read post]
6 Nov 2017, 10:40 pm by James Yang
Patent Guidance From the rules, the United States Patent and Trademark Office (USPTO) produces guides to implement the rules. [read post]
6 Nov 2017, 10:40 pm by James Yang
Patent Guidance From the rules, the United States Patent and Trademark Office (USPTO) produces guides to implement the rules. [read post]
6 Nov 2017, 12:50 pm by Thaddeus Hoffmeister
Rai Duke University School of Law; Duke Innovation & Entrepreneurship Initiative Abstract This is a brief of 72 IP professors opposing the claim in Oil States that the IPR procedure is unconstitutional.Petitioner argues that only a court – indeed, only a jury – has the power to decide that the United States Patent and Trademark Office erred in granting a patent. [read post]
4 Nov 2017, 9:10 pm by Patent Docs
Johns, and Kai Rajan of Finnegan Henderson Farabow Garrett & Dunner will provide guidance on leveraging the United States Patent & Trademark Office (USPTO) Examiner Count System to prosecute patents more effectively, provide insight into the count system, and offer strategies for interacting with patent examiners. [read post]
3 Nov 2017, 11:06 am by Dennis Crouch
Press Release: WASHINGTON – The Department of Commerce’s United States Patent and Trademark Office (USPTO) is initiating a two-year Diversion Pilot Program for patent and trademark practitioners. [read post]
29 Oct 2017, 6:46 am by Dennis Crouch
Department of Commerce’s United States Patent and Trademark Office (USPTO) will hold its first ever “Ask Me Anything” (AMA) on Reddit. [read post]
27 Oct 2017, 1:12 pm by Linda Holmes
Patent and Trademark Office (USPTO) spoke, along with Librarian Tiffany Mair, about the work of the 87 libraries in their system. [read post]
26 Oct 2017, 7:57 pm by Nikki Siesel
The New Santa Cruz Surf School, LLC (“Applicant”) filed an application with the United States Patent & Trademark Office (“USPTO”) for the mark SANTA CRUZ SURF SCHOOL in standard characters. [read post]
26 Oct 2017, 10:59 am by Audrey A Millemann
  The validity of Allergan’s Restasis patents had been challenged by Mylan and several other generic drug manufacturers in the United States Patent and Trademark Office’s Patent Trial and Appeal Board (PTAB) in inter partes review (IPR) proceedings. [read post]
26 Oct 2017, 10:59 am by Audrey A Millemann
  The validity of Allergan’s Restasis patents had been challenged by Mylan and several other generic drug manufacturers in the United States Patent and Trademark Office’s Patent Trial and Appeal Board (PTAB) in inter partes review (IPR) proceedings. [read post]
26 Oct 2017, 8:14 am
Soc’y 856 (2016) If you would like to read the full article and other published articles, subscribe to the Journal of the Patent and Trademark Office Society, for more information click here. [read post]
25 Oct 2017, 6:55 am by Overhauser Law Offices, LLC
Petitioner, Neptune Generics, LLC had filed a petition with the United States Patent and Trademark Offices against Eli Lilly & Company of Indianapolis, Indiana, challenging the validity of patent no. 7,772,209, Antifolate combination therapies, which has been issued by the USPTO. [read post]
23 Oct 2017, 4:11 am by Edith Roberts
Patent and Trademark Office to analyze the validity of existing patents, calling it “the innovation economy’s worst nightmare. [read post]